Science 37 Holdings Inc. (NASDAQ:SNCE) Q4 2022 Earnings Conference Call March 6, 2023 8:30 AM ET

Company Participants

David Coman - Chief Executive Officer

Mike Zaranek - Chief Financial Officer

Steven Halper - LifeSci Advisors

Conference Call Participants

Frank Takkinen - Lake Street Capital

Christine Rains - William Blair

Charles Rhyee - TD Cowen

Matt Hewitt - Craig Hallum

Evan Stover - Baird

Operator

Greetings. Welcome to the Science 37 fourth quarter and full year 2022 earnings conference call. At this time, all participants are in listen-only mode. A question and answer session will follow the formal presentation. If anyone should require Operator assistance during the conference, please press star, zero from your telephone keypad. Please note that this conference is being recorded.

I will now turn the conference over to Steven Halper with LifeSci Advisors. Steven, you may now begin.

Steven Halper

Thank you Rob, and thank you all for participating in today’s call. Joining me are David Coman, Chief Executive Officer, and Mike Zaranek, Chief Financial Officer.

Earlier today, Science 37 released financial results for the quarter ended December 31, 2022. A copy of the press release is available on the company’s website.

Before we begin, I’d like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based upon our current estimates of various assumptions and involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements. We encourage you to review our filings made with the Securities and Exchange Commission for a discussion of these risk factors, including in the Risk Factors section of the company’s most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today, and the company disclaims any obligation to update such statements for new information.

We believe that certain non-GAAP metrics are useful in evaluating our operational performance. We use these non-GAAP measures to evaluate our ongoing operations and for internal planning and forecasting purposes. Information about non-GAAP financial measures referenced, including a reconciliation of those measures to the most comparable GAAP measures can be found in our SEC filings and in earnings materials available on the Investor Relations portion of our website at investors.science37.com.